Anti-carbamylated protein (anti-CarP) antibodies, another group of antibodies resulting from post-translational modifications of proteins [10, 11], have been shown to be associated with the development of RA, and with radiographic progression, particularly in anti-CCP2–negative individuals [10, 12]. The gene discussed is AGBL2; the disease is rheumatoid arthritis.